Skip to main content
Erschienen in:

06.09.2018 | Original Article

A new checklist method enhances treatment compliance and response of behavioural therapy for primary monosymptomatic nocturnal enuresis: a prospective randomised controlled trial

verfasst von: Ahmet Metin Hascicek, Muhammet Fatih Kilinc, Yildiray Yildiz, Cem Nedim Yuceturk, Omer Gokhan Doluoglu

Erschienen in: World Journal of Urology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of the study was to demonstrate the benefits of a newly-established written checklist of behavioural instructions for monosymptomatic nocturnal enuresis.

Methods

From a total of 96 parents with children who complain of bedwetting three or more nights per week for at least 14 days, 79 were randomly divided into three groups. Group I (n = 27) were instructed to apply only behavioural therapy as a written guideline, Group II (n = 26) were instructed to apply behavioural therapy with a written checklist for parents to fully complete and Group III (n = 26) received desmopressin treatment plus verbal behavioural therapy. All participants were analysed in respect of compliance and the response rate to treatment over a time period of 8 weeks.

Results

A total of 63 participants completed the study period. The participants in all three groups were similar in terms of the age of the child and the parents, number of siblings, and the educational and economic status of the parents (p > 0.05). High rates of treatment compliance were determined for the participants with the checklist compared to those with written guideline. No statistically significant difference was determined between Group II and III in respect of compliance rates (p = 0.12). The treatment response rates of the participants in Group I were significantly lower compared to those of Group II and III (p = 0.001) with no statistical difference determined between Groups II and III (p = 0.15).

Conclusion

The success rate of behavioural therapy for MNE can be increased with the newly-designed method of a written checklist form of behavioural instructions.
Literatur
3.
Zurück zum Zitat Franco I, von Gontard A, De Gennaro M (2013) Evaluation and treatment of nonmonosymptomatic nocturnal enuresis: a standardization document from the International Children’s Continence Society. J Pediatr Urol 9:234–243CrossRefPubMed Franco I, von Gontard A, De Gennaro M (2013) Evaluation and treatment of nonmonosymptomatic nocturnal enuresis: a standardization document from the International Children’s Continence Society. J Pediatr Urol 9:234–243CrossRefPubMed
7.
Zurück zum Zitat Van Herzeele C, Alova I, Evans J et al (2009) Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response. J Urol 182(Suppl 4):2045–2049CrossRefPubMed Van Herzeele C, Alova I, Evans J et al (2009) Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response. J Urol 182(Suppl 4):2045–2049CrossRefPubMed
8.
Zurück zum Zitat Gawande A (2011) The checklist manifesto: how to get things right. Metropolitan. Books of Henry Holt and Co., New York Gawande A (2011) The checklist manifesto: how to get things right. Metropolitan. Books of Henry Holt and Co., New York
10.
Zurück zum Zitat Haynes AB, Weiser TG, Berry WR et al (2009) A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 360(5):491–499CrossRef Haynes AB, Weiser TG, Berry WR et al (2009) A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 360(5):491–499CrossRef
11.
Zurück zum Zitat Takala RSK, Pauniaho SL, Kotkansalo A et al (2011) A pilot study of the implementation of WHO surgical checklist in Finland: improvements in activities and communication. Acta Anaesthesiol Scand 55(10):1206–1214CrossRefPubMed Takala RSK, Pauniaho SL, Kotkansalo A et al (2011) A pilot study of the implementation of WHO surgical checklist in Finland: improvements in activities and communication. Acta Anaesthesiol Scand 55(10):1206–1214CrossRefPubMed
12.
Zurück zum Zitat Fai-Ngo Ng C, Wong SN, The Hong Kong Childhood Enuresis study Group (2005) Comparing alarms, desmopressin and combined treatment in Chinese enuretic children. Pediatr Nephrol 20:163–169CrossRefPubMed Fai-Ngo Ng C, Wong SN, The Hong Kong Childhood Enuresis study Group (2005) Comparing alarms, desmopressin and combined treatment in Chinese enuretic children. Pediatr Nephrol 20:163–169CrossRefPubMed
13.
Zurück zum Zitat Kruse S, Hellstrom AL, Hanson E, Hjälmås K, Sillén U, Swedish Enuresis Trial (SWEET) Group (2001) Treatment of primary mono symptomatic nocturnal enuresis with desmopressin: predictive factors. Br J Urol 88:572–576CrossRef Kruse S, Hellstrom AL, Hanson E, Hjälmås K, Sillén U, Swedish Enuresis Trial (SWEET) Group (2001) Treatment of primary mono symptomatic nocturnal enuresis with desmopressin: predictive factors. Br J Urol 88:572–576CrossRef
14.
Zurück zum Zitat Baeyens D, Lierman A, Roeyers H, Hoebeke P, Walle JV (2009) Adherence in children with nocturnal enuresis. J Pediatr Urol 5(2):105–109CrossRefPubMed Baeyens D, Lierman A, Roeyers H, Hoebeke P, Walle JV (2009) Adherence in children with nocturnal enuresis. J Pediatr Urol 5(2):105–109CrossRefPubMed
16.
Zurück zum Zitat De Guchtenaere A, Raes A, Walle CV et al (2009) Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray. J Urol 181(1):302–309CrossRefPubMed De Guchtenaere A, Raes A, Walle CV et al (2009) Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray. J Urol 181(1):302–309CrossRefPubMed
18.
Zurück zum Zitat Lazarus RS, Dodd HF, Majdandzic M et al (2016) The relationship between challenging parenting behaviour and childhood anxiety disorders. J Affect Dis 190:784–791CrossRefPubMed Lazarus RS, Dodd HF, Majdandzic M et al (2016) The relationship between challenging parenting behaviour and childhood anxiety disorders. J Affect Dis 190:784–791CrossRefPubMed
19.
Zurück zum Zitat Doganer YC, Aydogan U, Ongel K et al (2015) The prevalence and sociodemographic risk factors of enuresis nocturna among elementary school-age children. J Fam Med Prim Care 4:39–44CrossRef Doganer YC, Aydogan U, Ongel K et al (2015) The prevalence and sociodemographic risk factors of enuresis nocturna among elementary school-age children. J Fam Med Prim Care 4:39–44CrossRef
Metadaten
Titel
A new checklist method enhances treatment compliance and response of behavioural therapy for primary monosymptomatic nocturnal enuresis: a prospective randomised controlled trial
verfasst von
Ahmet Metin Hascicek
Muhammet Fatih Kilinc
Yildiray Yildiz
Cem Nedim Yuceturk
Omer Gokhan Doluoglu
Publikationsdatum
06.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 6/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2478-1

Neu im Fachgebiet Urologie

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Auf weichem Fahrradsattel ist nicht gut Kinder zeugen

Männer, die sich gern sportlich verausgaben, riskieren möglicherweise, fürs Vaterwerden nicht genug Kräfte übrig zu haben. In einer Studie fanden sich dafür zwar allenfalls schwache Anzeichen. Es gab jedoch eine Ausnahme.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.